Article Text
Commentary
General medicine
CETP inhibition improves the lipid profile but has no effect on clinical cardiovascular outcomes in high-risk patients
Statistics from Altmetric.com
Footnotes
Competing interests RR received funding for a steering committee on the use of PCSK9 inhibitors in familial hypercholesterolaemia for Eli Lilly. This development program was terminated earlier this year.
Provenance and peer review Commissioned; internally peer reviewed.